Found review

What it is

Found Health, Inc. runs an online weight-care program built around a clinician, a care plan and a menu of medications, rather than around one compounded drug. It also sells to employers and health plans. The menu covers compounded semaglutide and tirzepatide; brand-name GLP-1s including Wegovy (pen and pill), Ozempic, Zepbound, Mounjaro, Saxenda, Victoza, Rybelsus and Foundayo; the older weight medicines metformin, Contrave, topiramate and zonisamide; and a low-dose "microdosing" program using compounded semaglutide. Its insurance plans are accepted in 41 states, which it lists. For people aged 65 to 75 it also helps eligible Medicare Part D members apply for the Medicare GLP-1 Bridge program, which it says can bring Wegovy, Foundayo or Zepbound down to $50 a month, with no guarantee of coverage. Found says it is not affiliated with Novo Nordisk, Eli Lilly or Currax.

How it works

You start with a three-minute health assessment, or a free insurance check if you want to use your plan. A board-certified clinician reviews your profile, which Found says takes one to two days, and if a medication is appropriate it ships to your door. After that you check in with your clinician each month for your refill. How you meet depends on how you pay. On the insurance track, a live video visit is required, including before each refill, and each visit is billed to your insurance at your copay. On the cash track, care is by chat or text in most cases. Between visits you can message your clinician or support, use an AI assistant Found calls Aimee, and join a members' community. The store pages name several of its clinicians. Miss a scheduled video visit, or cancel it with less than 24 hours' notice, and Found charges a $30 no-show fee.

Pricing transparency

Found's compounded plans are all-in: each price covers clinical care, the medication and the membership, billed every 28 days (13 charges a year), and it stays the same at every dose. Month to month, compounded semaglutide is $289 cash or $199 with insurance, and compounded tirzepatide is $359 cash or $289 with insurance. Longer terms lower the rate: the "from $169" and "from $99" headlines are semaglutide on a 12-month plan, and tirzepatide falls to $239 cash or $179 with insurance on the same term. A monthly plan starts with a discounted first month, but the figures above are what you pay after it. The insurance price covers your clinical visits only: you still owe each visit's copay (about $30 for most members, Found says, plus any deductible), and the membership itself is not an insurance benefit. Insurance pricing isn't available to people on Medicare, Medicaid, TRICARE or Medi-Cal. Brand-name GLP-1s run on a separate plan at $149 every 28 days cash or $89 with insurance month to month ($99 or $49 on a 12-month plan), and the drug is billed separately through your own pharmacy, NovoCare or LillyDirect. Labs are not included in any plan. Refunds are narrow. The membership fee is refundable only if you cancel within three days of buying or before your first consultation, or if a clinician finds you can't take any of its treatments. Medication is non-refundable once dispensed, and renewals are non-refundable, so cancel or pause at least 48 hours before your renewal date.

Branded vs compounded

The compounded semaglutide and tirzepatide are weekly injections, each compounded with B12 or glycine by licensed 503A compounding pharmacies in the U.S. Found says every batch is third-party tested for potency, purity and sterility, though it doesn't name the pharmacies. Compounded drugs are not FDA-approved, and Found says so on its own pages. The brand-name drugs are the FDA-approved products, and the trial results Found quotes belong to them: an average 15% weight loss on Wegovy 2.4 mg over 68 weeks and 20% on Zepbound 15 mg over 72 weeks, against 2.4% and 3.1% with diet and exercise alone. It also notes that GLP-1s carry boxed warnings. Found's figure for its own members, an average 12% loss after a year, comes from 1,773 members who reported their weight weekly, not from a trial. If a GLP-1 isn't right for you, the same clinician can prescribe metformin, Contrave, topiramate or zonisamide on a generics plan that includes the medication.

Pros and watch-outs

The evidence behind what Found prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Oral semaglutide (Rybelsus): what the PIONEER trials actually showed

  A GLP-1 peptide in a pill is hard to pull off. PIONEER 1, 4, and 6 plus OASIS 1 — read straight from the primary literature.

How Found compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Gala Health

  A guided, program-style GLP-1 weight-care experience

  See Gala Health →
• HEHealthRX

  Low-cost compounded GLP-1 with overnight shipping and physician review

  See HealthRX →
• Trimi Health

  Low-cost compounded GLP-1 with thorough dosing guidance

  See Trimi Health →

Head-to-head: Found vs Ro · Found vs Hims · Found vs Mochi Health · Found vs PlushCare · Found vs SkinnyRx

More GLP-1 telehealth reviews: Breeze Meds · Synergy Rx · CareBareRX · He & She MD · Superior Remedies · Try Ageless